Comments on:

FDA approves first-of-a-kind seasonal flu vaccine

Back to the article » |
WASHINGTON (AP) — The Food and Drug Administration says it has approved the first seasonal flu vaccine made using animal cell technology, rather than the half-century egg method. The FDA approved Novartis' Flucelvax to prevent influenza in people 18 years and older. The new method has been promoted by U.S. health officials because it is faster than egg-based production and could speed up...

To learn more about commenting on and our community guidelines, please see our comments FAQ.